BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10444129)

  • 1. Is surveillance for stage 1 germ cell tumours of the testis appropriate outside a specialist centre?
    Jones A; Fergus JN; Chapman J; Houghton L
    BJU Int; 1999 Jul; 84(1):79-84. PubMed ID: 10444129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumours. Appraisal of its potential as adjuvant chemotherapy for stage 1 testis tumours.
    Oliver RT; Dhaliwal HS; Hope-Stone HF; Blandy JP
    Br J Urol; 1988 Jan; 61(1):53-8. PubMed ID: 2449257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of stage II seminoma.
    Warde P; Gospodarowicz M; Panzarella T; Catton C; Sturgeon J; Moore M; Jewett M
    J Clin Oncol; 1998 Jan; 16(1):290-4. PubMed ID: 9440755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
    Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
    Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.
    Cullen M; Huddart R; Joffe J; Gardiner D; Maynard L; Hutton P; Mazhar D; Shamash J; Wheater M; White J; Goubar A; Porta N; Witts S; Lewis R; Hall E;
    Eur Urol; 2020 Mar; 77(3):344-351. PubMed ID: 31901440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who should manage germ cell tumours of the testis?
    Mead GM
    BJU Int; 1999 Jul; 84(1):61-7. PubMed ID: 10444126
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience of the treatment for clinical Stage-1 seminoma over a period of 10 years].
    Zhang XQ; Liu ZW; Zhou FJ; Han H; Qin ZK; Ye YL; Li YH; Hou GL; Zhang ZL
    Chin J Cancer; 2010 Jan; 29(1):98-101. PubMed ID: 20038319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
    Culine S; Theodore C; Court BH; Perrin JL; Droz JP
    Br J Urol; 1997 Feb; 79(2):258-62. PubMed ID: 9052479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
    Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
    J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy treatment planning for testicular seminoma.
    Wilder RB; Buyyounouski MK; Efstathiou JA; Beard CJ
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e445-52. PubMed ID: 22436787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
    Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
    Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours.
    Cullen M
    Ann Oncol; 2012 Sep; 23 Suppl 10():x342-8. PubMed ID: 22987989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.